CN110669006A - Indeno isoquinoline compounds and preparation method thereof - Google Patents

Indeno isoquinoline compounds and preparation method thereof Download PDF

Info

Publication number
CN110669006A
CN110669006A CN201911004989.2A CN201911004989A CN110669006A CN 110669006 A CN110669006 A CN 110669006A CN 201911004989 A CN201911004989 A CN 201911004989A CN 110669006 A CN110669006 A CN 110669006A
Authority
CN
China
Prior art keywords
reaction
indeno
nmr
isoquinoline
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201911004989.2A
Other languages
Chinese (zh)
Inventor
徐允河
邱圣祺
李曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Science and Technology of China USTC
Original Assignee
University of Science and Technology of China USTC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Science and Technology of China USTC filed Critical University of Science and Technology of China USTC
Priority to CN201911004989.2A priority Critical patent/CN110669006A/en
Publication of CN110669006A publication Critical patent/CN110669006A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention discloses indenoisoquinoline compounds and a preparation method thereof, which are characterized in that a diene molecule with a prefabricated functional group is subjected to intramolecular diarylation reaction under the action of a palladium catalyst, a ligand and alkali metal acetate (such as sodium acetate) to obtain the indenoisoquinoline compounds. The method adopts a one-step method, realizes intramolecular diarylation reaction of allene molecules through palladium catalysis, has a simple system, can obtain the indeno isoquinoline compounds without additional treatment, is simple and easy to operate, is easy to operate, has wide substrate applicability, can tolerate various functional groups, and has a product yield remarkably higher than that of the traditional synthetic method. The invention successfully realizes the synthesis of the indeno isoquinoline compounds, and the indeno isoquinoline compounds with high yield can be easily prepared. The indenoisoquinoline compound can be directly used as an antitumor drug precursor or used as an antitumor drug precursor after being further modified. The invention provides a new synthesis means for developing a novel anti-tumor drug, and has economic practicability and industrial application prospect.

Description

Indeno isoquinoline compounds and preparation method thereof
Technical Field
The invention belongs to the technical field of indeno isoquinoline compounds, and particularly relates to an indeno isoquinoline compound and a preparation method thereof.
Background
The indenoisoquinoline and the derivatives thereof, as potential anti-tumor active compounds, have the advantages of more stable activity, lower cytotoxicity and the like compared with camptothecin topoisomerase I inhibitors (topotecan and the like). Some of the indenoisoquinoline derivatives have been subjected to preliminary antitumor activity tests (Song, Y., Shao, z., Dexheimer, t.s., Scher, e.s., Pommier, Y. & Cushman, m.j.med.chem.2010,53, 1979-:
Figure BDA0002242471350000011
regarding the construction of indenoisoquinoline skeleton, the currently reported synthesis method mainly uses (2, 2-dimethoxyethyl) benzylamine and benzaldehyde or aryl imine to condense in hydrochloric acid. However, the synthesis yield of the reaction is very low, the substrate universality is also narrow, and the research and the application of the indeno isoquinoline compounds are limited. Therefore, a simple and efficient preparation method of the indeno isoquinoline compound is urgently needed to be developed.
Disclosure of Invention
The invention aims to provide an indeno isoquinoline compound and a preparation method thereof, and the preparation of the indeno isoquinoline compound is realized through a allene intramolecular diarylation reaction so as to overcome the defects in the prior art.
The invention relates to an indeno isoquinoline compound, which is characterized in that the indeno [1,2-c ] isoquinoline skeleton structure is shown as a formula II:
substituent R in indenoisoquinoline compounds of formula II1、R2、R3、R4、R6、R7、R8、R9And R12Each independently selected from alkyl, alkoxy, halogen or hydrogen; substituent R10And R11Each independently selected from hydrogen, alkyl, aryl or heteroaryl.
In a particular embodiment, R10And R11One of which is hydrogen and the other is tert-butyl.
In a particular embodiment, R10And R11One of which is hydrogen and the other is phenyl.
In a particular embodimentIn the scheme, R10And R11One of which is hydrogen and the other is heteroaryl.
Specifically, the indenoisoquinoline compounds comprise compounds with the following structures:
Figure BDA0002242471350000022
Figure BDA0002242471350000031
specifically, the indenoisoquinoline compounds include the following compounds:
Figure BDA0002242471350000032
the invention also relates to a preparation method of the indenoisoquinoline compound, which is characterized by comprising the following steps: using allene molecules with prefabricated functional groups, adopting a one-step method to synthesize an indenoisoquinoline skeleton,
wherein the substituent R1、R2、R3、R4、R6、R7、R8、R9And R12Each independently selected from alkyl, alkoxy, halogen or hydrogen;
wherein the substituent R5Selected from acyl, sulfonyl or sulfinyl;
wherein the substituent R10And R11Each independently selected from hydrogen, alkyl, aryl or heteroaryl;
wherein the substituent X is halogen;
as used herein, acyl refers to alkyl-C (═ O) -or aryl-C (═ O) -.
As used herein, sulfonyl means alkyl-S (═ O)2-or aryl-S (═ O)2-。
As used herein, sulfinyl refers to alkyl-S (═ O) -or aryl-S (═ O) -.
As used herein, alkyl includes, but is not limited to, C1-6Alkyl groups such as methyl, ethyl, n-propyl, isopropyl, t-butyl, n-pentyl, n-hexyl, and the like.
As used herein, alkoxy includes, but is not limited to, C1-6Alkoxy, such as methoxy, ethoxy, isopropoxy, and the like.
As used herein, halogen includes fluorine, chlorine, bromine and iodine.
As used herein, aryl groups may be selected from phenyl, naphthyl, and substituted aryl (e.g., substituted phenyl); the substituted aryl group includes, but is not limited to, alkyl groups, alkoxy groups, halogen groups, and the like substituted aryl groups (e.g., phenyl groups), such as methyl groups, methoxy groups, fluorine atoms, or chlorine atoms substituted aryl groups (e.g., phenyl groups).
The term "heteroaryl" denotes a monovalent aromatic heterocyclic mono-or polycyclic ring system of 5 to 12 ring atoms comprising 1,2, 3 or 4 heteroatoms selected from N, O and S, the remaining ring atoms being carbon. Examples of heteroaryl groups include pyrrolyl, furyl, thienyl, imidazolyl, and the like,
Figure BDA0002242471350000041
Oxazolyl, thiazolyl, triazolyl,
Figure BDA0002242471350000042
Oxadiazolyl, thiadiazolyl, tetrazolyl, pyridyl, pyrazinyl, pyrazolyl, pyridazinyl, pyrimidinyl, triazinyl, aza
Figure BDA0002242471350000043
Radical diaza
Figure BDA0002242471350000044
Basic group, hetero
Figure BDA0002242471350000045
Azolyl, benzofuranyl, isothiazolyl, benzothienyl, indolyl, isoindolyl, isobenzofuranyl, benzimidazolyl
Figure BDA0002242471350000046
Azolyl, benzisoyl
Figure BDA0002242471350000047
Azolyl, benzothiazolyl, benzisothiazolyl, benzo
Figure BDA0002242471350000048
Oxadiazolyl, benzothiadiazolyl, benzotriazolyl, purinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, benzothienyl, benzoquinolinyl, and benzoisoquinolinyl groups. Heteroaryl groups may be substituted, for example, with alkyl, alkoxy, halo, and the like.
In a particular embodiment, R5Selected from acetyl or p-toluenesulfonyl. In a particular embodiment, R10And R11One of which is hydrogen and the other is phenyl.
The specific operation steps are as follows:
under the protective atmosphere, a divinyl compound and a derivative thereof, namely a compound of a formula 1 are used as reaction substrates, the compound of the formula 1, a palladium catalyst, a ligand and alkali metal acetate are added into an organic solvent, wherein the molar ratio of the compound of the formula 1 to the palladium catalyst is 100: 1-10: 1, the molar ratio of the palladium catalyst to the ligand is 1: 1-1: 2, the molar ratio of the compound of the formula 1 to the acetate is 2: 1-1: 5, an arylation reaction is carried out for 8-36 hours at 80-140 ℃, a reaction end point is determined by a thin-layer chromatography dot plate, and then column chromatography is carried out to obtain a corresponding indeno-isoquinoline compound II or a corresponding product marked by an enantiomer, a racemate, a diastereoisomer or an isotope thereof.
In some embodiments, the palladium catalyst is tetrakistriphenylphosphine palladium, bis (dibenzylideneacetone) palladium, or tris (dibenzylideneacetone) dipalladium.
In some embodiments, the ligand is triphenylphosphine, tris (m-methoxyphenyl) phosphine, tris (p-dimethylaminophenyl) phosphine, or 4, 5-bisdiphenylphosphine-9, 9-dimethylxanthene.
In some embodiments, the protective atmosphere is nitrogen, argon, or helium.
In some embodiments, the molar ratio of the compound of formula 1 to the palladium catalyst is from 100:1 to 10:1, preferably 10: 1.
In some embodiments, the molar ratio of palladium catalyst to ligand is from 1:1 to 1:2, preferably 1: 1.
In some embodiments, the molar ratio of the compound of formula 1 to alkali metal acetate is from 2:1 to 1:5, preferably 1: 3.
In some embodiments, the alkali metal acetate is selected from sodium acetate, potassium acetate, and the like, preferably sodium acetate.
In some embodiments, the organic solvent is selected from polar organic solvents such as N, N-dimethylformamide, N-dimethylacetamide or dimethylsulfoxide, preferably N, N-dimethylformamide.
In some embodiments, the reaction temperature is 80-140 ℃, preferably 100 ℃.
In some embodiments, the reaction time is 8 to 36 hours, preferably 8 hours.
According to the synthesis method of the indenoisoquinoline compound, a one-step method is adopted, allene molecules with prefabricated functional groups are subjected to intramolecular diarylation reaction under the action of a palladium catalyst, a ligand and alkali metal acetate (such as sodium acetate), and the indenoisoquinoline compound is obtained; the existing synthesis method of the indenoisoquinoline compound is realized by using (2, 2-dimethoxyethyl) benzylamine and benzaldehyde or aryl imine through condensation reaction, so that the reaction yield of the final step is low, and the waste of valuable raw materials is serious. Because the invention adopts a one-step method, realizes intramolecular diarylation reaction of allene molecules by palladium catalysis, has simple system, can obtain indeno isoquinoline compounds without additional treatment, is simple and easy to operate, wide in substrate applicability, capable of tolerating various functional groups, and has the product yield remarkably higher than that of the traditional synthetic method (the total synthetic yield is generally lower than 10%). The invention not only successfully realizes the synthesis of the indeno isoquinoline compounds, but also simplifies the traditional synthesis method, and the indeno isoquinoline compounds with high yield can be easily prepared. The indenoisoquinoline compound can be directly used as an antitumor drug precursor or used as an antitumor drug precursor after being further modified. The invention provides a new synthesis means for developing a novel anti-tumor drug, and has economic practicability and industrial application prospect.
Detailed Description
The reagents used in the examples were purchased from Annaige corporation.
First substrate synthetic route:
Figure BDA0002242471350000051
under the protection of nitrogen atmosphere, a rotor is put into a 100mL round-bottom flask, 4mmol of cuprous bromide, 20mmol of aldehyde, 30mmol of o-bromobenzylamine and 30mmol of alkyne are weighed and placed in a bottle, 40mL of toluene is added as a solvent, and the reaction is refluxed for 12 hours. The reaction was then cooled to room temperature, filtered through celite, and the filtrate washed with saturated ammonium chloride solution until the aqueous phase was no longer visibly blue. The aqueous phases are combined and extracted once with 20mL of ethyl acetate. The organic phases were combined, washed once with 20mL of saturated sodium chloride solution, then dried over anhydrous sodium sulfate and the solvent was removed using a rotary evaporator. The residue was purified by column chromatography to give the product (petroleum ether/ethyl acetate in a ratio of 99:1 as eluent).
Figure BDA0002242471350000061
Under the protection of nitrogen atmosphere, a rotor is put into a 100mL round-bottom flask, 10mmol of amine, 2mmol of p-Dimethylaminopyridine (DMAP), 20mmol of p-toluenesulfonyl chloride and 25mmol of triethylamine are weighed and dissolved in 20mL of dichloromethane, and the mixture is refluxed for two days. The reaction mother liquor was then washed three times with 20mL of saturated sodium bicarbonate solution, the organic phase was dried over anhydrous sodium sulfate and the solvent was removed using a rotary evaporator. The residue was purified by column chromatography to give the product (petroleum ether/ethyl acetate in a ratio of 40:1 as eluent).
Figure BDA0002242471350000062
Under the protection of nitrogen, a rotor was put into a 50mL round-bottom flask, and 5mmol of propargylamide, 0.5mmol of DBU and 10mL of methylene chloride were weighed as solvents and stirred at room temperature for 12 hours. The solvent was then removed directly using a rotary evaporator. The residue was purified by column chromatography to give product I (petroleum ether/ethyl acetate in a ratio of 40:1 as eluent).
Second substrate synthetic route:
Figure BDA0002242471350000063
under the protection of nitrogen atmosphere, a rotor is put into a 25mL round-bottom flask, 20mmol of aldehyde, 20mmol of p-toluenesulfonamide and 5mL of tetraethoxysilane are weighed as solvents, and the reaction is stirred for 5 hours at 160 ℃. Then directly pouring the reaction into 100mL of anhydrous ether while the reaction is hot, stirring vigorously, standing for half an hour after the solid is completely separated out, and then carrying out suction filtration to obtain a white or light yellow solid product.
Figure BDA0002242471350000071
Under the protection of nitrogen atmosphere, a rotor is put into a 100mL round-bottom flask, 40mmol of alkyne is weighed and dissolved in 40mL of toluene, and 20mL of 1M dimethyl zinc toluene solution is added while stirring. Stirring for 2 hours at room temperature, directly adding 10mmol of imine into a reaction system under the protection of nitrogen atmosphere, heating to 50 ℃, and stirring for 12 hours. The reaction was then cooled to room temperature and washed three times with 20mL of saturated ammonium chloride. The aqueous phases are combined and extracted once with 20mL of ethyl acetate. The organic phases were combined, washed once with 20mL of saturated sodium chloride solution, then dried over anhydrous sodium sulfate and the solvent was removed using a rotary evaporator. The residue was purified by column chromatography to give the product (petroleum ether/ethyl acetate at 20:1 ratio as eluent).
Figure BDA0002242471350000072
Under the protection of nitrogen atmosphere, a rotor is put into a 100mL round bottom flask, 10mmol of propargylamide and 15mmol of sodium hydride are weighed, 20mL of dry DMF is added as a solvent, and the mixture is stirred at room temperature until the reaction solution is an orange solution and no bubbles are generated. 20mmol of o-bromobenzyl bromide were then added directly to the reaction and the resulting mixture was stirred further at room temperature. After confirming the completion of the reaction using thin layer chromatography, 5mL of water was added dropwise to quench the reaction. The quenched reaction solution was directly poured into a large beaker containing 100mL of water, 50mL of petroleum ether and 10mL of ethyl acetate, and the mixture was stirred vigorously until the solid was completely precipitated. And (3) carrying out suction filtration to obtain a white or light pink solid, and recrystallizing by using a mixed solvent with the ratio of petroleum ether to ethyl acetate being 10:1 to obtain a target product.
Figure BDA0002242471350000081
Under the protection of nitrogen, a rotor was put into a 50mL round-bottom flask, and 5mmol of benzylpropargylamide, 0.5mmol of DBU and 10mL of methylene chloride were weighed and stirred at room temperature for 12 hours. The solvent was then removed directly using a rotary evaporator. The residue was purified by column chromatography to give product I (petroleum ether/ethyl acetate in a ratio of 40:1 as eluent).
Example 1: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000082
Under an argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a thin-layer chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 92%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277 and found 294.1275. It was confirmed that the white solid product obtained by the above reaction was 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 2: preparation of 6-phenyl-4-methoxy-6H-indeno [1,2-c ] isoquinoline (2b)
Figure BDA0002242471350000091
1b as the starting substrate for the reaction to produce the desired product 2b, in a manner essentially identical to the procedure of example 1.
The product yield is 83%; a white solid;1H NMR(400MHz,CDCl3)δ9.28(s,1H),8.02(t,J=8.7Hz,2H),7.56(d,J=8.0Hz,1H),7.53–7.42(m,2H),7.30–7.21(m,3H),7.15–7.11(m,2H),7.01(dd,J=8.3,2.3Hz,1H),6.89(d,J=2.2Hz,1H),5.26(s,1H),3.81(s,3H).13C NMR(101MHz,CDCl3)δ160.45,154.31,153.34,150.68,140.62,133.54,133.40,133.29,130.67,129.04,128.92,128.15,127.60,127.12,125.74,123.12,121.13,113.48,110.87,55.52,51.86.HRMS(ESI):m/z Calcd.for C23H18NO[M+H]+:324.1383,found:324.1410.
example 3: preparation of 2-methyl-6-phenyl-6H-indeno [1,2-c ] isoquinoline (2c)
Figure BDA0002242471350000092
1c as the starting substrate for the reaction to produce the desired product 2c, for a reaction time of 20 hours, in a manner substantially identical to the procedure of example 1.
The product yield is 80%; a white solid;1H NMR(400MHz,CDCl3)δ9.34(s,1H),8.04–7.99(m,1H),7.62–7.57(m,1H),7.52–7.45(m,2H),7.28–7.22(m,3H),7.21–7.15(m,3H),7.13–7.09(m,2H),5.24(s,1H),3.05(s,3H).13C NMR(101MHz,CDCl3)δ156.2,152.8,149.1,141.0,137.9,134.5,134.2,133.0,130.4,129.8,129.0,128.7,128.1,127.6,127.3,127.0,126.1,123.4,122.2,51.6,19.5.HRMS(ESI):m/z Calcd.for C23H18N[M+H]+:308.1434,found:308.1438.
example 4: preparation of 8-phenyl-8H-benzo [6,7] indeno [1,2-c ] isoquinoline (2d)
Figure BDA0002242471350000101
1d as the starting substrate for the reaction to produce the desired product 2d, for a reaction time of 24 hours, in a manner substantially identical to the procedure of example 1.
The product yield is as follows: 60 percent; a light yellow solid;1H NMR(400MHz,CDCl3)δ9.91(d,J=8.4Hz,1H),9.39(s,1H),8.05–7.98(m,1H),7.92–7.86(m,1H),7.78–7.68(m,2H),7.64–7.59(m,1H),7.57–7.52(m,1H),7.51–7.44(m,2H),7.42(d,J=8.3Hz,1H),7.27–7.18(m,3H),7.13–7.07(m,2H),5.24(s,1H).13C NMR(101MHz,CDCl3)δ156.5,152.8,147.3,140.0,135.3,134.7,133.4,132.8,130.5,129.2,129.0,128.7,128.6,128.3,128.2,127.2,127.1,126.8,126.0,125.8,125.6,123.2,122.5,52.1.HRMS(ESI):m/z Calcd.for C26H18N[M+H]+:344.1434,found:344.1438.
example 5: preparation of 6-phenyl-2, 3-dimethoxy-6H-indeno [1,2-c ] isoquinoline (2e)
Figure BDA0002242471350000102
1e as the starting substrate for the reaction to produce the desired product 2e for 24 hours in substantially the same manner as in example 1.
The product yield is as follows: 79 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.40(s,1H),8.07–7.95(m,1H),7.63–7.53(m,1H),7.53–7.42(m,2H),7.31–7.17(m,3H),7.15–7.06(m,2H),7.00(d,J=8.1Hz,1H),6.87(d,J=8.1Hz,1H),5.24(s,1H),4.18(s,3H),3.90(s,3H).13C NMR(101MHz,CDCl3)δ153.64,153.60,152.6,144.9,142.3,141.0,134.9,133.5,132.9,130.5,129.0,128.7,128.0,127.5,127.0,126.3,123.4,120.2,112.8,61.6,56.6,51.3.HRMS(ESI):m/z Calcd.for C24H20NO2[M+H]+:354.1489,found:354.1492.
example 6: preparation of 6-phenyl-4-chloro-6H-indeno [1,2-c ] isoquinoline (2f)
Figure BDA0002242471350000111
1f as the starting substrate for the reaction to produce the objective product 2f in a reaction time of 14 hours in substantially the same manner as in example 1.
The product yield is as follows: 93 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.31(s,1H),8.06–8.01(m,2H),7.59–7.47(m,3H),7.42(dd,J=8.1,1.9Hz,1H),7.31–7.25(m,4H),7.13–7.08(m,2H),5.26(s,1H).13C NMR(101MHz,CDCl3)δ153.7,153.2,150.1,139.6,139.2,134.3,133.9,133.1,130.9,129.2,129.0,128.13,128.10,128.0,127.4,126.5,125.3,123.3,121.3,51.8.HRMS(ESI):m/z Calcd.for C22H15ClN[M+H]+:328.0888,found:328.0893.
example 7: preparation of 6-phenyl-6H-benzo [ f ] indeno [1,2-c ] isoquinoline (2g)
Figure BDA0002242471350000112
1g of the objective product was prepared as the starting substrate for the reaction in an amount of 2g for 14 hours in substantially the same manner as in example 1.
The product yield is as follows: 70 percent; a light yellow solid;1H NMR(400MHz,CDCl3)δ9.34(s,1H),8.75(d,J=8.4Hz,1H),8.19(dt,J=7.7,0.9Hz,1H),7.91(d,J=8.8Hz,1H),7.84(dd,J=7.9,1.4Hz,1H),7.78(d,J=8.8Hz,1H),7.56(ddd,J=8.0,7.0,1.1Hz,1H),7.50–7.39(m,3H),7.35(td,J=7.4,1.2Hz,1H),7.18–7.07(m,5H),5.85(s,1H).13C NMR(101MHz,CDCl3)δ158.2,152.7,148.5,139.9,139.1,134.6,133.5,133.4,129.1,128.7,128.54,128.47,128.19,128.17,127.9,127.7,127.1,127.01,126.98,126.2,126.1,124.5,120.8,54.8.HRMS(ESI):m/z Calcd.for C26H18N[M+H]+:344.1434,found:344.1436.
example 8: preparation of 6-phenyl-9-fluoro-6H-indeno [1,2-c ] isoquinoline (2H)
Figure BDA0002242471350000121
1h as the initial substrate of the reaction, and the reaction time is 22 hours, and the preparation method is basically the same as the operation steps in the example 1.
The product yield is as follows: 96 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.25(s,1H),8.12(d,J=7.6Hz,1H),7.66–7.55(m,2H),7.49–7.42(m,1H),7.35–7.21(m,6H),7.09(d,J=6.3Hz,2H),5.24(s,1H).13C NMR(101MHz,CDCl3)δ160.2(d,J=249.7Hz),153.9(d,J=2.1Hz),152.5(d,J=5.5Hz),148.3,140.3,140.2,134.5,130.4,129.1,128.7(d,J=8.9Hz),128.2,128.0,127.7,127.2,126.0(d,J=8.4Hz),124.8,121.3(d,J=25.5Hz),120.3,111.8(d,J=20.7Hz),51.9.HRMS(ESI):m/z Calcd.for C22H15FN[M+H]+:312.1183,found:312.1188.
example 9: preparation of 6H-indeno [1,2-c ] isoquinoline (2i)
Figure BDA0002242471350000131
1i as the starting substrate for the reaction to produce the objective product 2i, for a reaction time of 21 hours, in substantially the same manner as in example 1.
The product yield is as follows: 37 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.28(s,1H),8.14(d,J=7.5Hz,1H),8.05(d,J=8.2Hz,1H),7.98(dd,J=8.3,1.0Hz,1H),7.75(ddd,J=8.2,6.9,1.2Hz,1H),7.64(d,J=7.4Hz,1H),7.57(ddd,J=8.1,6.9,1.1Hz,1H),7.49(t,J=7.4Hz,1H),7.41(td,J=7.4,1.2Hz,1H),4.14(s,2H).13C NMR(101MHz,CDCl3)δ154.1,152.5,142.8,142.1,133.6,131.2,130.8,128.9,127.5,127.3,126.3,125.0,123.1,120.3,100.0,33.3.HRMS(ESI):m/z Calcd.for C16H12N[M+H]+:218.0964,found:218.0972.
example 10: preparation of 6-tert-butyl-6H-indeno [1,2-c ] isoquinoline (2j)
Figure BDA0002242471350000132
1j as the starting substrate for the reaction to produce the objective product 2j for a reaction time of 36 hours in substantially the same manner as in example 1.
The product yield is as follows: 46 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.12(s,1H),7.96(d,J=8.3Hz,2H),7.90(d,J=8.2Hz,1H),7.59–7.49(m,2H),7.43–7.31(m,2H),7.21(td,J=7.5,1.2Hz,1H),4.16(s,1H),0.88(s,9H).13C NMR(101MHz,CDCl3)δ155.27,152.61,147.28,142.17,135.06,134.33,129.58,128.61,127.50,127.41,126.45,125.98,125.84,125.52,120.06,55.87,36.72,29.15.HRMS(ESI):m/z Calcd.for C20H20N[M+H]+:274.1590,found:274.1598.
example 11: preparation of 6- (4-methylphenyl) -6H-indeno [1,2-c ] isoquinoline (2k)
Figure BDA0002242471350000141
1k as the starting substrate for the reaction to produce the desired product 2k, for a reaction time of 12 hours, in a manner substantially identical to the procedure of example 1.
The product yield is as follows: 99 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.30(s,1H),8.13(d,J=7.5Hz,1H),7.99(dd,J=7.2,1.5Hz,1H),7.60(d,J=8.4Hz,1H),7.52–7.40(m,3H),7.34–7.26(m,2H),7.05(d,J=7.8Hz,2H),6.98(d,J=8.1Hz,2H),5.21(s,1H),2.28(s,3H).13CNMR(101MHz,CDCl3)δ154.15,153.41,148.91,140.56,137.34,136.68,134.55,133.32,130.72,129.72,128.91,128.20,128.12,127.98,127.62,126.21,124.81,123.46,120.30,51.58,21.14.HRMS(ESI):m/z Calcd.for C23H18N[M+H]+:308.1434,found:308.1439.
example 12: preparation of 6- (4-methoxyphenyl) -6H-indeno [1,2-c ] isoquinoline (2l)
1l of the reaction starting substrate was used to prepare 2l of the objective product by a reaction time of 12 hours in substantially the same manner as in example 1.
The product yield is as follows: 98 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.31(s,1H),8.15(d,J=7.6Hz,1H),8.07–7.97(m,1H),7.62(d,J=8.3Hz,1H),7.55–7.42(m,3H),7.36–7.29(m,2H),7.04(d,J=8.7Hz,2H),6.80(d,J=8.7Hz,2H),5.22(s,1H),3.75(s,3H).13C NMR(101MHz,CDCl3)δ158.63,154.06,153.43,149.02,140.52,134.58,133.30,132.33,130.70,129.11,128.91,128.18,128.13,127.62,126.21,124.79,123.44,120.29,114.41,55.19,51.17.HRMS(ESI):m/z Calcd.for C23H18NO[M+H]+:324.1383,found:324.1385.
example 13: preparation of 6- (2-methoxyphenyl) -6H-indeno [1,2-c ] isoquinoline (2m)
Figure BDA0002242471350000151
1m as the starting substrate for the reaction to produce the desired product 2m for 12 hours, in substantially the same manner as in example 1.
The product yield is as follows: 54 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.31(s,1H),8.13(d,J=7.4Hz,1H),8.03(dd,J=7.0,1.4Hz,1H),7.61–7.39(m,5H),7.30(td,J=7.5,1.2Hz,1H),7.20(t,J=7.0Hz,1H),7.08(br,1H),6.62(br,1H),6.29(br,1H),6.01(br,1H),4.14(br,3H).13C NMR(101MHz,CDCl3)δ157.30,154.44,153.13,149.26,140.85,134.97,133.21,130.63,128.84,128.06,127.39,126.12,124.84,123.74,121.13,120.21,111.02,55.80,43.84.HRMS(ESI):m/z Calcd.for C23H18NO[M+H]+:324.1388,found:324.1396.
example 14: preparation of 6- (4-chlorophenyl) -6H-indeno [1,2-c ] isoquinoline (2n)
Figure BDA0002242471350000152
1n as the starting substrate for the reaction to produce the desired product 2n, for a reaction time of 14 hours, in substantially the same manner as in example 1.
The product yield is as follows: 91%; a white solid;1H NMR(400MHz,CDCl3)δ9.33(s,1H),8.14(d,J=7.6Hz,1H),8.06–8.02(m,1H),7.63–7.59(m,1H),7.55–7.44(m,3H),7.37–7.31(m,2H),7.27–7.22(m,3H),7.15–7.10(m,2H),5.31(s,1H),0.00(s,1H).13C NMR(101MHz,CDCl3)δ154.25,153.53,148.69,140.61,140.49,134.40,133.30,130.76,129.01,128.93,128.19,128.13,127.70,127.11,126.24,124.85,123.41,120.32,51.95.HRMS(ESI):m/zCalcd.for C22H15ClN[M+H]+:328.0893,found:328.0892.
example 15: preparation of 6- (2-thienyl) -6H-indeno [1,2-c ] isoquinoline (2o)
Figure BDA0002242471350000161
1o as the starting substrate for the reaction to produce the desired product 2o for 16 hours, in substantially the same manner as in example 1.
The product yield is as follows: 57 percent; a white solid;1H NMR(400MHz,CDCl3)δ9.31(s,1H),8.13(dt,J=7.6,1.0Hz,1H),8.04(d,J=7.7Hz,1H),7.70(dq,J=8.4,0.9Hz,1H),7.59–7.39(m,4H),7.34(td,J=7.4,1.2Hz,1H),7.28(ddd,J=2.9,1.3,0.5Hz,1H),7.18(dd,J=5.0,3.0Hz,1H),6.55(dd,J=5.0,1.3Hz,1H),5.46(s,1H).13C NMR(101MHz,CDCl3)δ153.82,153.51,147.54,140.50,140.19,133.74,133.38,130.81,128.92,128.18,128.09,127.79,126.77,126.51,126.28,124.76,123.23,122.08,120.35,46.99.HRMS(ESI):m/z Calcd.forC20H14NS[M+H]+:300.0847,found:300.0852.
example 16: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000171
Under an argon atmosphere, 1 a' (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which had been previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid, wherein the yield of the product is 36%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 17: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000172
Under an argon atmosphere, 1a (0.2mmol), tetrakistriphenylphosphine palladium (0.02mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube using N, N-dimethylformamide (3mL) as a reaction solvent, the reaction tube was put into an oil bath which had been previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a thin-layer chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 55%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 18: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000181
Under an argon atmosphere, 1a (0.2mmol), bis (dibenzylideneacetone) palladium (0.02mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 64%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 19: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000191
Under an argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), triphenylphosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 34%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 20: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000201
Under argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (p-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which had been previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 81%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 21: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000202
Under argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (p-dimethylaminophenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, the reaction tube was put into an oil bath which had been previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a thin-layer chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid, wherein the yield of the product is 85%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 22: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000211
Under argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), 4, 5-bis diphenylphosphine-9, 9-dimethylxanthene (0.01mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and N, N-dimethylformamide (3mL) was added to the reaction tube as a reaction solvent, followed by placing the reaction tube into an oil bath which had been previously heated to 100 ℃ and stirring for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 74%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 23: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000221
Under argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.002mmol), tris (m-methoxyphenyl) phosphine (0.004mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was added thereto, the reaction tube was put into an oil bath which had been previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid, wherein the yield of the product is 67%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 24: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Under an argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.1mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid, wherein the yield of the product is 36%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 25: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000232
Under an argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (1.0mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid, wherein the yield of the product is 94%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 26: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000241
Under argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, the reaction tube was put into an oil bath which had been previously heated to 80 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a thin-layer chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 78%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and NMR carbon Spectroscopy: (MR)13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 27: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000251
Under an argon atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 140 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 83%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 28: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000261
Under an argon atmosphere, 1a "(0.2 mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid, wherein the yield of the product is 11%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 29: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000262
Under argon atmosphere, 1 a' (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, the reaction tube was put into an oil bath which had been previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a Thin Layer Chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid, wherein the yield of the product is 67%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 30: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000271
Under a nitrogen atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a thin-layer chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 92%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).
Example 31: preparation of 6-phenyl-6H-indeno [1,2-c ] isoquinoline (2a)
Figure BDA0002242471350000281
Under a helium atmosphere, 1a (0.2mmol), tris (dibenzylideneacetone) dipalladium (0.01mmol), tris (m-methoxyphenyl) phosphine (0.02mmol) and sodium acetate (0.6mmol) were added to a reaction tube, and after a rubber stopper was added to the reaction tube, N-dimethylformamide (3mL) was used as a reaction solvent, the reaction tube was put into an oil bath which was previously heated to 100 ℃ and stirred for reaction for 8 hours. And (3) determining the reaction end point by using a thin-layer chromatography (TLC) spot plate, lifting the reaction tube from the oil bath pot when the TLC plate shows that the reaction raw material 1a completely disappears, cooling to room temperature, adding 20mL of water to quench the reaction, extracting by using ethyl acetate, spin-drying the solvent, and performing column chromatography to obtain the target product 2a as a white solid with the yield of 92%.
By nuclear magnetic resonance hydrogen spectroscopy (1H NMR and nuclear magnetic resonance carbon Spectroscopy: (13C NMR), analyzing the white solid product, and performing molecular weight determination by High Resolution Mass Spectrometry (HRMS);1H NMR(400MHz,CDCl3)δ9.32(s,1H),8.14(d,J=7.6Hz,1H),8.07–8.01(m,1H),7.62–7.58(m,1H),7.54–7.43(m,3H),7.37–7.31(m,2H),7.28–7.22(m,3H),7.14–7.10(m,2H),5.30(s,1H).13C NMR(101MHz,CDCl3)δ154.2,153.5,148.7,140.6,140.5,134.4,133.3,130.7,129.0,128.9,128.2,128.1,127.7,127.1,126.2,124.8,123.4,120.3,51.9.HRMS(ESI):m/z Calcd.for C22H16N[M+H]+294.1277, found 294.1275. the white solid product obtained by the above reaction was confirmed to be 6-phenyl-6H-indeno [1,2-c ]]Isoquinoline (2 a).

Claims (10)

1. An indeno isoquinoline compound, which is characterized by having an indeno [1,2-c ] isoquinoline skeleton structure shown in a formula II:
Figure FDA0002242471340000011
wherein R is1、R2、R3、R4、R6、R7、R8、R9And R12Each independently selected from alkyl, alkoxy, halogen or hydrogen, and
R10、R11each independently selected from hydrogen, alkyl, aryl or heteroaryl.
2. The compound of claim 1, wherein the compound is selected from the group consisting of:
Figure FDA0002242471340000012
3. a compound selected from
Figure FDA0002242471340000021
4. A method for preparing indenoisoquinoline compounds,
Figure FDA0002242471340000022
the method is characterized in that:
adding the compound shown in the formula 1, a palladium catalyst, a ligand and alkali metal acetate into an organic solvent, and synthesizing the indenoisoquinoline compound shown in the formula II or a corresponding product marked by an enantiomer, a racemate, a diastereoisomer or an isotope thereof by adopting a one-step method:
wherein R is1、R2、R3、R4、R6、R7、R8、R9And R12Each independently selected from alkyl, alkoxy, halogen or hydrogen;
R5selected from acyl, sulfonyl or sulfinyl;
R10and R11Each independently selected from hydrogen, alkyl, aryl or heteroaryl;
x is halogen.
5. The method of claim 4, wherein the molar ratio of the compound of formula 1 to the palladium catalyst is from 100:1 to 10:1, the molar ratio of the palladium catalyst to the ligand is from 1:1 to 1:2, and the molar ratio of the compound of formula 1 to the alkali metal acetate is from 2:1 to 1: 5.
6. The process of claim 4, wherein the palladium catalyst is tetrakistriphenylphosphine palladium, bis (dibenzylideneacetone) palladium, or tris (dibenzylideneacetone) dipalladium, or
Wherein the ligand is triphenylphosphine, tri (m-methoxyphenyl) phosphine, tri (p-dimethylaminophenyl) phosphine or 4, 5-bisdiphenylphosphine-9, 9-dimethylxanthene.
7. The process according to claim 4, wherein the alkali metal acetate is sodium acetate or the organic solvent is selected from polar organic solvents such as N, N-dimethylformamide, N-dimethylacetamide or dimethylsulfoxide, preferably N, N-dimethylformamide.
8. The method according to claim 4, wherein the method is performed under a protective atmosphere, preferably the protective atmosphere is nitrogen, argon or helium.
9. The process of claim 4, wherein the reaction temperature is 80-140 ℃, or the reaction time is 8-36 hours.
10. The method of claim 4, wherein the indenoisoquinoline-based compound is a compound according to any one of claims 1 to 3.
CN201911004989.2A 2019-10-22 2019-10-22 Indeno isoquinoline compounds and preparation method thereof Withdrawn CN110669006A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911004989.2A CN110669006A (en) 2019-10-22 2019-10-22 Indeno isoquinoline compounds and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911004989.2A CN110669006A (en) 2019-10-22 2019-10-22 Indeno isoquinoline compounds and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110669006A true CN110669006A (en) 2020-01-10

Family

ID=69083574

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911004989.2A Withdrawn CN110669006A (en) 2019-10-22 2019-10-22 Indeno isoquinoline compounds and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110669006A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115340485A (en) * 2022-08-25 2022-11-15 河南师范大学 Method for synthesizing indole terpene analogue through palladium-catalyzed serial Heck/carbonyl ortho-alkylation reaction

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120014913A1 (en) * 2010-07-16 2012-01-19 Abbott Laboratories Process for preparing antiviral compounds
WO2019018539A1 (en) * 2017-07-19 2019-01-24 California Institute Of Technology Methods for preparing bis-tetrahydroisoquinoline-containing compounds
CN110041257A (en) * 2019-04-25 2019-07-23 河南师范大学 A method of synthesis indenes spiral shell indenes [1,2-c] isoquinolin trione compounds
CN110105359A (en) * 2019-04-25 2019-08-09 河南师范大学 A method of synthesis indenes spiral shell iso-indoles [2,1-b] isoquinolin trione compounds
CN110330485A (en) * 2019-07-25 2019-10-15 中国科学技术大学 A kind of indenoisoquinoline class compound and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120014913A1 (en) * 2010-07-16 2012-01-19 Abbott Laboratories Process for preparing antiviral compounds
WO2019018539A1 (en) * 2017-07-19 2019-01-24 California Institute Of Technology Methods for preparing bis-tetrahydroisoquinoline-containing compounds
CN110041257A (en) * 2019-04-25 2019-07-23 河南师范大学 A method of synthesis indenes spiral shell indenes [1,2-c] isoquinolin trione compounds
CN110105359A (en) * 2019-04-25 2019-08-09 河南师范大学 A method of synthesis indenes spiral shell iso-indoles [2,1-b] isoquinolin trione compounds
CN110330485A (en) * 2019-07-25 2019-10-15 中国科学技术大学 A kind of indenoisoquinoline class compound and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115340485A (en) * 2022-08-25 2022-11-15 河南师范大学 Method for synthesizing indole terpene analogue through palladium-catalyzed serial Heck/carbonyl ortho-alkylation reaction
CN115340485B (en) * 2022-08-25 2023-10-03 河南师范大学 Method for synthesizing indole terpene analogues by palladium-catalyzed cascade Heck/carbonyl ortho-alkylation reaction

Similar Documents

Publication Publication Date Title
Hadden et al. Synthesis and reactivity of hexahydropyrroloquinolines
CN110330485B (en) Indeno isoquinoline compounds and preparation method thereof
CN112812122B (en) Method for selectively synthesizing beta-indole-alpha, beta-unsaturated carbonyl compound and pyrano [2,3-b ] indole
CN110790763A (en) Process for preparing pyridobipyrimidine and pyridobipyrazole derivatives
Setsune et al. Synthesis and atropisomerism of meso-tetraarylporphyrins with mixed meso-aryl groups having ortho-substituents
CN110669006A (en) Indeno isoquinoline compounds and preparation method thereof
JP2010500367A (en) Process for producing substituted-1,2,3,4-tetrahydroisoquinoline derivatives
Ito et al. Synthesis and redox behavior of 1, 2-dihydro-1-oxabenz [a] azulen-2-ones
CN109293700B (en) Chiral diphosphine ligand, preparation method, intermediate and application thereof
Sundberg et al. 3-(3-Pyrrolyl) thiopyrrolidones as precursors of benzo [1, 2-b: 4, 3-b'] dipyrroles. Synthesis of structures related to the phosphodiesterase inhibitors PDE-I and PDE-II
CN111471046A (en) Carbazole indoquinone derivative and preparation method and application thereof
CN109384794B (en) Protonic acid catalyzed tetracyclic indole skeleton synthesizing process
EP3480187B1 (en) Method for preparing indenoisoquinoline derivatives
Clemens et al. Selective N2-Alkylation of 1H-Indazoles and 1H-Azaindazoles
CN114716438B (en) Benzo [7,8] indolizine [1,2-c ] quinoline skeleton derivative and synthetic method thereof
Kiehne et al. Synthesis of 2, 8-disubstituted analogues of Tröger’s Base
CN115353529A (en) Chiral spiro compound, preparation method and application thereof
Cowden et al. Synthesis of the putative structure of 5, 6-dihydrobicolorine
Smula et al. The Synthesis of (±)-Cordrastine. A New Route to the Phthalideisoquinoline System
TWI674265B (en) Method for producing flavonoid and its derivative
Althagafi et al. Base-promoted regioselective synthesis of 1, 2, 3, 4-terahydroquinolines and quinolines from N-boc-3-piperidone
Orda-Zgadzaj et al. Photoswitchable macrocycles incorporating acridane moieties
CN112778203B (en) Process for the preparation of 1H-indazole-3-carboxylic acid derivatives and granisetron and lonidamine
CN111217813B (en) Pyrrolo [3,2-c ] quinoline compound and preparation method thereof
Kiren et al. A facile synthesis of 4-azaisoindoles and their transformation into novel pyrrole-fused 2-pyridones

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20200110

WW01 Invention patent application withdrawn after publication